ModelEdge

Scinai Immunotherapeutics Ltd
SCNI
Filing Type20-F
Filing Date3/31/2026
Updated4/1/26, 5:36 AM

Filing

20-F
Earnings Release

Exhibits

20-FAnnual and Transition Report of Foreign Private Issuers
EX-1.1AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF SCINAI IMMUNOTHERAPEUTICS LTD
EX-2.3DESCRIPTION OF SHARE CAPITAL
EX-4.16LEASE AGREEMENT DATED AUGUST 11, 2020, BETWEEN SCINAI BIOPHARMA AND P L.A.R. MANAGEMENT ASSETS LTD. AND R. MATRY ADV.ATTORNEY COMPANY
EX-8.1LIST OF SUBSIDIARIES OF THE COMPANY
EX-12.1CERTIFICATION
EX-12.2CERTIFICATION
EX-13.1CERTIFICATION
EX-13.2CERTIFICATION
EX-15.1CONSENT OF ZIV HAFT, CERTIFIED PUBLIC ACCOUNTANTS IN ISRAEL AND A MEMBER OF BDO, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE REGISTRANT
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic